Global Awareness. Local Impact.

CLA's mission is to promote disease awareness, prevention, education, advocacy, and research. Headquartered in Pittsburgh and with offices in Milwaukee, the Community Liver Alliance has grown to have a national presence while still holding true to a mission to invest in local communities and give voice to patients and providers.

Learn More
Volunteer

News & Information

Advocacy

Advocacy
Liver Disease Does Not Discriminate
There is 80 to 100 million people in the USA that have Fatty Liver Disease and most do not even know they have it. Liver Disease does not discriminate. It affects any age, social economics and race. Liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.
COVID-19 Response
Ensure funding for COVID-19 and liver disease public health programs, research, vaccine dissemination; ensure that people living with liver disease are not disproportionately impacted and do not experience unnecessary or discriminatory health care or treatment disruptions.
Health Disparities
Address inequities in the care of people impacted by liver disease, especially the excess incidence rate of liver cancer in black men in America.
Liver Health Policy
Advance the U.S. NASH Action Plan, and ensure patients with liver disease perspectives are represented in relevant legislative packages: COVID-19, diabetes, and obesity.
Liver Health Regulations
Work with regulators to establish logical pathways to consistently approve therapies for liver diseases, particularly rare liver diseases.
Research Funding
Advocate for funding that ensures meaningful growth of vital liver disease research and the improving of liver health.
Transplant
Urgently respond to the inequities that impact organ transplantation; modernize the U.S. Organ Donation system, improve care for transplant patients, and increase the number of available organs.
Viral Hepatitis
Increase support for hepatitis programs and raise awareness of viral hepatitis; advocate for the elimination of viral hepatitis .
Value
Advance health care policies that reflect each person’s unique needs and drive access to personalized, patient-centric care.
Patient Access and Reimbursement
Support policy solutions that curb patients’ health care expenses; advocate for the smoothing and capping of out-of-pocket costs in Medicare Part D.
Previous
Next
Learn More
0
PEOPLE IN USA WITH LIVER DISEASE
0
PEOPLE IN USA WITH FATTY LIVER DISEASE
0 %
RISE IN LIVER CANCER SINCE 1980
Huber

Cindy Huber

Director of Opperations, Donate Life Wisconsin
"CLA Is an amazing resource for patients and their families as well as the healthcare professionals who provide care…"

Upcoming Program & Events

CLA Event 1
a5b522_600aab52d64b44e8bf3dabd99cdc0790_mv2
CLA Event 3
CLA Event 2
CLA Event 4
a5b522_c5f99a2079c94685904e244050fb91c2_mv2_d_5184_3456_s_4_2
a5b522_3be131b09ce34a6381cb85f997038b37_mv2_d_4000_3000_s_4_2
a5b522_bb2badba75194f0ca50fa9f4b1eb9bd3_mv2_d_5184_3456_s_4_2 (1)
Previous
Next

Events Search and Views Navigation

Event Views Navigation

Today
Virtual

CLA Post AASLD Conference

Virtual

Program Overview The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including […]